A Fournier, G Lagrue, J P Nakache, D Salmon, M Kazandjian, A Baulon, J C Legrand, J Menard
{"title":"【螺内酯治疗原发性高血压:对原发性高醛固酮增多症的筛查价值及疗效预测】。","authors":"A Fournier, G Lagrue, J P Nakache, D Salmon, M Kazandjian, A Baulon, J C Legrand, J Menard","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":78795,"journal":{"name":"Therapeutique (La Semaine des hopitaux)","volume":"49 2","pages":"127-30"},"PeriodicalIF":0.0000,"publicationDate":"1973-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Treatment of essential arterial hypertension with spironolactone: its value for the screening of primary hyperaldosteronism and prediction of its efficacy].\",\"authors\":\"A Fournier, G Lagrue, J P Nakache, D Salmon, M Kazandjian, A Baulon, J C Legrand, J Menard\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":78795,\"journal\":{\"name\":\"Therapeutique (La Semaine des hopitaux)\",\"volume\":\"49 2\",\"pages\":\"127-30\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1973-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutique (La Semaine des hopitaux)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutique (La Semaine des hopitaux)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Treatment of essential arterial hypertension with spironolactone: its value for the screening of primary hyperaldosteronism and prediction of its efficacy].